InvestorsHub Logo
Followers 12
Posts 743
Boards Moderated 0
Alias Born 04/14/2011

Re: Drugdoctor post# 26511

Saturday, 09/15/2012 9:52:43 AM

Saturday, September 15, 2012 9:52:43 AM

Post# of 402396
Cargo, that is very interesting that some digging by different people led to the same potential company. Now that it is not the middle of the night, my head is a little clearer and I see that Elite would not be exporting any drugs to Hong Kong. However, i do think it is likely that the Branded, Prescription product is a brompheniramine phenylephrine product. That product does not currently exist in the U.S. And according to the PR the Hong Kong based company will supply the formula and submit a NDA application for this new brand name prescription product.
The reason why this makes sense to me is that pseudoephedrine has really fallen out of favor, and as Elite is looking looking to get the brompheniramine product back on the market, combining it with phenylephrine is the next logical step. However, if Advance owns the international patent for the brompheniramine phenylephrine combo, then Elite would not be able to manufacture that without an agreement with the patent holder.
If that is the case, then Elite would have been the one contacting Advance about the manufacturing of the drug, not the other way around. Puts a whole new spin on it for me.
Again, I could be totally wrong, but this seems the most ikely scenario for me.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News